Trexquant Investment’s VanEck Pharmaceutical ETF PPH Stock Holding History

Trexquant Investment’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,429	Closed	-$219K	–	1857
2025 Q3	$219K	Sell	2,429 -722	-23%	-$63.2K	﹤0.01%	1485
2025 Q2	$277K	Buy	+3,151	New	+$273K	﹤0.01%	1396
2024 Q3	–	Sell	-4,664	Closed	-$427K	–	1802
2024 Q2	$427K	Buy	+4,664	New	+$416K	0.01%	1291
2024 Q1	–	Sell	-6,195	Closed	-$504K	–	1710
2023 Q4	$504K	Buy	+6,195	New	+$486K	0.01%	1081
2023 Q3	–	Sell	-3,508	Closed	-$276K	–	1736
2023 Q2	$276K	Buy	+3,508	New	+$275K	0.01%	1219

Other funds holding PPH

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trexquant Investment's PPH Position: Q4 2025 in Review

Trexquant Investment sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2025, closing a stake of 2,429 shares — an estimated $219K sold.

Trexquant Investment first reported a position in PPH in Q2 2023 and held it in 5 quarters. The position peaked at $504K in Q4 2023. 146 funds tracked by Wall St. Rank hold PPH as of Q4 2025.

Trexquant Investment reported no remaining VanEck Pharmaceutical ETF position as of Q4 2025 after selling out during the quarter.
Trexquant Investment sold 2,429 VanEck Pharmaceutical ETF shares in Q4 2025, an estimated $219K.
Trexquant Investment first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and held it in 5 quarters.
Trexquant Investment's VanEck Pharmaceutical ETF position peaked at $504K in Q4 2023.
146 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.